An Open-Label Evaluation of Safety of the IONSY(TM) System [Fentanyl Iontophoretic Transdermal System (40ug)] [Fentanyl] for Management of Acute Post-Operative Pain in Pediatric Patients.

Trial Profile

An Open-Label Evaluation of Safety of the IONSY(TM) System [Fentanyl Iontophoretic Transdermal System (40ug)] [Fentanyl] for Management of Acute Post-Operative Pain in Pediatric Patients.

Withdrawn prior to enrolment
Phase of Trial: Phase III

Latest Information Update: 30 Sep 2017

At a glance

  • Drugs Fentanyl (Primary)
  • Indications Postoperative pain
  • Focus Adverse reactions
  • Sponsors ALZA Corporation
  • Most Recent Events

    • 10 Jul 2012 This trial is recruiting in France.
    • 04 May 2010 New source identified and integrated (United Kingdom Clinical Research Network record 4726).
    • 30 Oct 2009 Planned end date changed from 1 Oct 2010 to 1 Dec 2010 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top